Kyowa Hakko Kirin Co., Ltd.;Ultragenyx Pharmaceutical Inc.
发明人:
Kakkis, Emil,San Martin, Javier,Sudo, Tomohiro
申请号：
AU2015275128
公开号：
AU2015275128B2
申请日:
2015.05.29
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
The present invention provides compositions and methods for treating a hypophosphatemic disorder, such as X-linked hypophosphatemia (XLH). The method entails administering to a subject a pharmaceutical composition containing an anti-FGF23 ligand, wherein the dosing regimen of the pharmaceutical is designed to reach effective and efficient control of FGF23 activity.
